Traders should monitor for future announcements of actual offerings under this shelf registration, which could lead to equity dilution or debt issuance. The lack of immediate capital raise limits near-term impact, but the overhang of potential dilution may weigh on sentiment if market conditions deteriorate.
Price Chart
Executive Summary
ADC Therapeutics SA has announced the effectiveness of a shelf registration (Form S-3) filed with the SEC, allowing the company to issue unspecified amounts of securities from time to time. The filing became effective on March 16, 2026, enabling future capital raises under flexible terms.
Key Facts
- Shelf registration on Form S-3 has become effective as of March 16, 2026.
- The company may now offer and sell unspecified amounts of securities in one or more offerings.
- No specific offering size, pricing, or securities type is disclosed in the filing.
- This is a routine capital markets update, not an IPO or immediate follow-on offering.
Financial Impact
Not specified
Risk Factors
- Potential for future equity dilution if common stock is issued under the shelf.
- Market perception of negative timing if an offering is launched during weak performance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000834 |
| Document: 9999999995-26-000834-index.html | 9999999995-26-000834 |
| Document: 9999999995-26-000834.txt | 9999999995-26-000834 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 8-K | $1.70 $1.52 | ▼ −10.59% | ▼ −9.44% | $1.50 (−11.47%) |
Aug 6, 2026 11w ago | Press Release | $1.13 $1.05 | ▼ −7.08% | ▼ −8.29% | $1.50 (+33.19%) |
Jul 2, 2026 16w ago | 8-K | $1.19 $1.30 | ▲ +9.24% | ▲ +8.31% | $1.50 (+26.47%) |
Jun 3, 2026 20w ago | 8-K | $1.32 $1.06 | ▼ −19.70% | ▼ −17.14% | $1.50 (+14.02%) |
May 4, 2026 25w ago | 8-K | $3.68 $3.48 | ▼ −5.43% | ▼ −8.37% | $1.50 (−59.10%) |
Apr 20, 2026 27w ago | DEFA14A | $4.25 $3.76 | ▼ −11.53% | ▼ −12.44% | $1.50 (−64.59%) |
Mar 17, 2026 31w ago | EFFECT | $4.11 $3.94 | ▼ −4.14% | ▼ −1.48% | $1.50 (−63.38%) |
Mar 10, 2026 32w ago | S-3 | $4.88 $4.01 | ▲ +17.83% | ▲ +15.64% | $1.50 (+69.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers